BioRem Net Interest Income vs Income Before Tax Analysis

BRM Stock

CAD 2.75 0.03 1.10%

BioRem financial indicator trend analysis is way more than just evaluating BioRem Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioRem Inc is a good investment. Please check the relationship between BioRem Net Interest Income and its Income Before Tax accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Interest Income vs Income Before Tax

Net Interest Income vs Income Before Tax Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioRem Inc Net Interest Income account and Income Before Tax. At this time, the significance of the direction appears to have almost no relationship.

The correlation between BioRem's Net Interest Income and Income Before Tax is 0.16. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of BioRem Inc, assuming nothing else is changed. The correlation between historical values of BioRem's Net Interest Income and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of BioRem Inc are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Net Interest Income i.e., BioRem's Net Interest Income and Income Before Tax go up and down completely randomly.

Correlation Coefficient

0.16

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on BioRem income statement and is an important metric when analyzing BioRem Inc profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most indicators from BioRem's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioRem Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, BioRem's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to about 736.3 K in 2025, whereas Enterprise Value Multiple is likely to drop 3.18 in 2025.

	2022	2023	2024	2025 (projected)
Total Revenue	28.9M	25.2M	28.9M	18.5M
Depreciation And Amortization	350.6K	382.7K	344.4K	281.4K

Total Revenue Depreciation And Amortization

BioRem fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Current Deferred Revenue	Good Will	Intangible Assets	Non Currrent Assets Other
Total Assets		0.1	0.61	0.65	0.74	0.65	-0.36	0.59	0.59	0.86	0.59	0.77	0.36	0.31	0.56	0.48	-0.49	0.62	0.99	-0.48	-0.1	0.7	0.71	-0.22	-0.56	0.84
Short Long Term Debt Total	0.1		0.27	0.55	-0.54	0.45	0.77	0.23	-0.35	0.09	-0.35	0.21	-0.43	0.77	0.12	0.42	0.19	0.65	0.09	0.46	-0.7	0.41	0.33	-0.17	-0.05	0.12
Other Current Liab	0.61	0.27		0.41	0.33	0.45	-0.17	0.65	0.45	0.74	0.45	0.38	-0.02	0.49	0.29	0.03	-0.41	0.46	0.57	-0.36	-0.4	0.33	0.31	0.03	-0.04	0.66
Total Current Liabilities	0.65	0.55	0.41		0.17	0.85	0.3	0.51	0.07	0.48	0.05	0.88	0.03	0.73	0.38	0.6	-0.21	0.97	0.65	0.04	-0.47	0.96	0.92	-0.65	-0.52	0.63
Total Stockholder Equity	0.74	-0.54	0.33	0.17		0.29	-0.82	0.38	0.8	0.7	0.8	0.47	0.6	-0.23	0.39	0.11	-0.53	0.09	0.73	-0.66	0.35	0.28	0.35	-0.14	-0.45	0.7
Property Plant And Equipment Net	0.65	0.45	0.45	0.85	0.29		0.16	0.7	0.21	0.63	0.19	0.76	-0.15	0.78	0.46	0.64	-0.23	0.88	0.6	-0.2	-0.54	0.8	0.88	-0.7	-0.26	0.72
Net Debt	-0.36	0.77	-0.17	0.3	-0.82	0.16		0.01	-0.85	-0.39	-0.86	0.06	-0.67	0.59	-0.31	0.25	0.36	0.38	-0.35	0.56	-0.65	0.22	0.12	-0.22	0.26	-0.3
Retained Earnings	0.59	0.23	0.65	0.51	0.38	0.7	0.01		0.23	0.64	0.22	0.64	-0.17	0.63	0.17	0.19	-0.68	0.62	0.54	-0.58	-0.73	0.55	0.57	-0.48	0.16	0.78
Cash	0.59	-0.35	0.45	0.07	0.8	0.21	-0.85	0.23		0.65	1.0	0.17	0.66	-0.19	0.55	-0.06	-0.41	0.03	0.56	-0.46	0.36	0.07	0.18	0.02	-0.46	0.61
Non Current Assets Total	0.86	0.09	0.74	0.48	0.7	0.63	-0.39	0.64	0.65		0.65	0.54	0.21	0.38	0.58	0.33	-0.38	0.49	0.79	-0.48	-0.16	0.49	0.5	-0.14	-0.33	0.91
Cash And Short Term Investments	0.59	-0.35	0.45	0.05	0.8	0.19	-0.86	0.22	1.0	0.65		0.15	0.66	-0.2	0.55	-0.06	-0.41	0.01	0.56	-0.46	0.37	0.05	0.16	0.06	-0.45	0.6
Net Receivables	0.77	0.21	0.38	0.88	0.47	0.76	0.06	0.64	0.17	0.54	0.15		0.15	0.52	0.26	0.46	-0.47	0.85	0.77	-0.32	-0.36	0.94	0.91	-0.66	-0.48	0.73
Common Stock Shares Outstanding	0.36	-0.43	-0.02	0.03	0.6	-0.15	-0.67	-0.17	0.66	0.21	0.66	0.15		-0.52	0.16	-0.17	-0.35	-0.11	0.4	-0.06	0.6	0.07	0.08	0.11	-0.64	0.24
Non Current Liabilities Total	0.31	0.77	0.49	0.73	-0.23	0.78	0.59	0.63	-0.19	0.38	-0.2	0.52	-0.52		0.28	0.41	-0.03	0.85	0.26	-0.01	-0.84	0.67	0.62	-0.53	0.09	0.46
Inventory	0.56	0.12	0.29	0.38	0.39	0.46	-0.31	0.17	0.55	0.58	0.55	0.26	0.16	0.28		0.39	-0.1	0.38	0.53	-0.29	0.06	0.4	0.45	-0.13	-0.44	0.49
Other Current Assets	0.48	0.42	0.03	0.6	0.11	0.64	0.25	0.19	-0.06	0.33	-0.06	0.46	-0.17	0.41	0.39		0.14	0.56	0.48	0.13	-0.2	0.55	0.61	-0.28	-0.43	0.3
Other Stockholder Equity	-0.49	0.19	-0.41	-0.21	-0.53	-0.23	0.36	-0.68	-0.41	-0.38	-0.41	-0.47	-0.35	-0.03	-0.1	0.14		-0.24	-0.5	0.61	0.29	-0.28	-0.36	0.2	0.03	-0.56
Total Liab	0.62	0.65	0.46	0.97	0.09	0.88	0.38	0.62	0.03	0.49	0.01	0.85	-0.11	0.85	0.38	0.56	-0.24		0.6	-0.03	-0.63	0.93	0.9	-0.66	-0.38	0.65
Total Current Assets	0.99	0.09	0.57	0.65	0.73	0.6	-0.35	0.54	0.56	0.79	0.56	0.77	0.4	0.26	0.53	0.48	-0.5	0.6		-0.46	-0.07	0.7	0.71	-0.18	-0.6	0.78
Short Term Debt	-0.48	0.46	-0.36	0.04	-0.66	-0.2	0.56	-0.58	-0.46	-0.48	-0.46	-0.32	-0.06	-0.01	-0.29	0.13	0.61	-0.03	-0.46		0.05	-0.15	-0.23	0.1	-0.16	-0.5
Common Stock	-0.1	-0.7	-0.4	-0.47	0.35	-0.54	-0.65	-0.73	0.36	-0.16	0.37	-0.36	0.6	-0.84	0.06	-0.2	0.29	-0.63	-0.07	0.05		-0.42	-0.39	0.42	-0.39	-0.32
Accounts Payable	0.7	0.41	0.33	0.96	0.28	0.8	0.22	0.55	0.07	0.49	0.05	0.94	0.07	0.67	0.4	0.55	-0.28	0.93	0.7	-0.15	-0.42		0.93	-0.66	-0.5	0.66
Current Deferred Revenue	0.71	0.33	0.31	0.92	0.35	0.88	0.12	0.57	0.18	0.5	0.16	0.91	0.08	0.62	0.45	0.61	-0.36	0.9	0.71	-0.23	-0.39	0.93		-0.71	-0.49	0.66
Good Will	-0.22	-0.17	0.03	-0.65	-0.14	-0.7	-0.22	-0.48	0.02	-0.14	0.06	-0.66	0.11	-0.53	-0.13	-0.28	0.2	-0.66	-0.18	0.1	0.42	-0.66	-0.71		0.14	-0.45
Intangible Assets	-0.56	-0.05	-0.04	-0.52	-0.45	-0.26	0.26	0.16	-0.46	-0.33	-0.45	-0.48	-0.64	0.09	-0.44	-0.43	0.03	-0.38	-0.6	-0.16	-0.39	-0.5	-0.49	0.14		-0.38
Non Currrent Assets Other	0.84	0.12	0.66	0.63	0.7	0.72	-0.3	0.78	0.61	0.91	0.6	0.73	0.24	0.46	0.49	0.3	-0.56	0.65	0.78	-0.5	-0.32	0.66	0.66	-0.45	-0.38

Click cells to compare fundamentals

BioRem Account Relationship Matchups

BioRem fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	22.0M	19.2M	20.7M	24.1M	27.7M	15.1M
Short Long Term Debt Total	828.2K	5.7M	4.7M	4.2M	4.8M	2.9M
Other Current Liab	3.3M	3.4M	4.2M	2.7M	2.5M	2.0M
Total Current Liabilities	7.8M	13.2M	12.9M	13.9M	16.0M	16.8M
Total Stockholder Equity	13.5M	2.0M	4.5M	6.7M	7.7M	6.0M
Property Plant And Equipment Net	1.4M	1.1M	1.0M	2.0M	2.3M	2.4M
Net Debt	(8.0M)	1.2M	971.1K	1.9M	1.7M	1.8M
Retained Earnings	(7.0M)	(5.7M)	(4.1M)	(1.9M)	(1.7M)	(1.8M)
Cash	8.9M	4.5M	3.8M	2.3M	2.6M	3.1M
Non Current Assets Total	3.7M	3.0M	3.0M	3.5M	3.1M	1.9M
Cash And Short Term Investments	8.9M	4.5M	3.8M	2.3M	2.6M	2.7M
Net Receivables	7.6M	10.1M	12.2M	15.1M	17.3M	18.2M
Common Stock Shares Outstanding	39.5M	37.4M	17.6M	17.1M	19.7M	22.9M
Liabilities And Stockholders Equity	22.0M	19.2M	20.7M	24.1M	27.7M	15.1M
Non Current Liabilities Total	610.6K	4.0M	3.3M	3.5M	4.0M	4.2M
Inventory	944.8K	901.7K	888.0K	901.1K	1.0M	764.8K
Other Current Assets	857.3K	658.9K	870.6K	2.3M	2.1M	1.1M
Other Stockholder Equity	2.2M	2.2M	2.3M	2.4M	2.1M	2.0M
Total Liab	8.4M	17.2M	16.2M	17.4M	20.0M	21.0M
Total Current Assets	18.3M	16.2M	17.8M	20.6M	23.7M	12.4M
Short Term Debt	217.6K	1.7M	1.5M	723.2K	650.8K	1.2M
Accounts Payable	1.8M	5.1M	4.7M	6.1M	7.1M	7.4M
Accumulated Other Comprehensive Income	1.1M	597.3K	1.4M	1.3M	1.5M	1.5M
Current Deferred Revenue	2.5M	3.0M	2.6M	4.3M	5.0M	5.2M
Net Tangible Assets	12.9M	11.7M	13.5M	2.0M	2.3M	2.1M
Property Plant Equipment	262.5K	372.9K	1.4M	1.1M	1.3M	1.4M
Net Invested Capital	13.5M	7.0M	8.8M	9.7M	8.7M	8.1M
Net Working Capital	10.5M	2.9M	4.9M	6.7M	6.0M	5.8M
Property Plant And Equipment Gross	4.8M	4.9M	5.2M	5.8M	6.7M	5.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for BioRem Stock Analysis

When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC